Business Description
Nanoform Finland PLC
ISIN : FI4000330972
Total Employee Number:
139Compare
Compare
Traded in other countries / regions
NANOFH.FinlandNANOFS.Sweden4YL.Germany IPO Date
2020-07-08Description
Nanoform Finland PLC is a nanoparticle medicine-enabling company. The company works together with pharma and biotech partners to reduce attrition in clinical trials and enhance their molecules' formulation performance through its nano-forming services. Its patented and scalable Controlled Expansion of Supercritical Solutions (CESS) technology produces nano-formed API particles as small as 10nm. This enables poorly soluble molecules in the pharmaceutical pipeline to progress into clinical development by increasing their rate of dissolution and improving their bioavailability. Its technology provides novel opportunities in many value-enhancing drug delivery applications. Geographically, the company generates maximum revenue from Europe, followed by the United States and other regions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.23 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.52 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.45 | |||||
Beneish M-Score | -1.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.1 | |||||
3-Year EBITDA Growth Rate | 12.2 | |||||
3-Year EPS without NRI Growth Rate | 9.6 | |||||
3-Year FCF Growth Rate | 16.6 | |||||
3-Year Book Growth Rate | -23.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 20.51 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 60.25 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.74 | |||||
9-Day RSI | 34.23 | |||||
14-Day RSI | 40.73 | |||||
3-1 Month Momentum % | 49.72 | |||||
6-1 Month Momentum % | -19.96 | |||||
12-1 Month Momentum % | -26.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.02 | |||||
Quick Ratio | 3.97 | |||||
Cash Ratio | 3.46 | |||||
Days Inventory | 201.71 | |||||
Days Sales Outstanding | 65.78 | |||||
Days Payable | 807.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3 | |||||
Shareholder Yield % | -0.99 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 89.4 | |||||
Operating Margin % | -470.69 | |||||
Net Margin % | -404.87 | |||||
EBITDA Margin % | -309.86 | |||||
FCF Margin % | -450.18 | |||||
OCF Margin % | -424.85 | |||||
ROE % | -34.51 | |||||
ROA % | -27.47 | |||||
ROIC % | -56.86 | |||||
3-Year ROIIC % | -20.94 | |||||
ROC (Joel Greenblatt) % | -62.46 | |||||
ROCE % | -30.11 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 16.63 | |||||
PB Ratio | 1.65 | |||||
Price-to-Tangible-Book | 1.66 | |||||
EV-to-EBIT | -3.33 | |||||
EV-to-EBITDA | -4.2 | |||||
EV-to-Revenue | 13.02 | |||||
EV-to-FCF | -2.89 | |||||
Price-to-GF-Value | 0.42 | |||||
| Price-to-Net-Current-Asset-Value | 4.99 | |||||
| Price-to-Net-Cash | 6.81 | |||||
Earnings Yield (Greenblatt) % | -30.03 | |||||
FCF Yield % | -27.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanoform Finland PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.944 | ||
| EPS (TTM) (€) | -0.19 | ||
| Beta | 0.9064 | ||
| 3-Year Sharpe Ratio | 0.02 | ||
| 3-Year Sortino Ratio | 0.05 | ||
| Volatility % | 131.38 | ||
| 14-Day RSI | 40.73 | ||
| 14-Day ATR (€) | 0.038741 | ||
| 20-Day SMA (€) | 0.79465 | ||
| 12-1 Month Momentum % | -26.23 | ||
| 52-Week Range (€) | 0.385 - 1.27 | ||
| Shares Outstanding (Mil) | 85.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanoform Finland PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanoform Finland PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-11 | In 122 days | ||
| Third quarter earnings results for 2026 | 2026-11-11 | In 122 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-20 | In 39 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 39 days | ||
| First quarter earnings conference call for 2026 | 2026-05-19 11:00 | 0.88 (-2.12%) | ||
| First quarter earnings results for 2026 | 2026-05-19 08:10 | 0.88 (-2.12%) | ||
| General meeting for 2026 | 2026-04-21 10:00 | 0.54 (-3.21%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-26 10:00 | 0.73 (+1.25%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-26 08:10 | 0.73 (+1.25%) | ||
| Annual report for 2025 | 2026-02-26 | 0.73 (+1.25%) |
Show
Entries
Nanoform Finland PLC Frequently Asked Questions
What is Nanoform Finland PLC(STU:4YL)'s stock price today?
The current price of STU:4YL is €0.75. The 52 week high of STU:4YL is €1.27 and 52 week low is €0.39.
When is next earnings date of Nanoform Finland PLC(STU:4YL)?
The next earnings date of Nanoform Finland PLC(STU:4YL) is 2026-08-20.
Does Nanoform Finland PLC(STU:4YL) pay dividends? If so, how much?
Nanoform Finland PLC(STU:4YL) does not pay dividend.
Press Release
Articles on Nanoform Finland PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers